The IVVE study is a randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events. It was delightful to speak with Prof Mark Loeb (McMaster University, Hamilton, Canada) about his presentation at the American College of Cardiology Annual Meeting 2022.
- What is known about the effects of the influenza vaccine on mortality and cardiovascular outcomes in patients with heart failure? (00:22)
- What were the aims and design of the IVVE study? (01:22)
- What were the primary outcome findings of the study? (03:00)
- Were any other variables found to modify the benefits of vaccination? (04:36)
- On the basis of these findings, what are your recommendations for future clinical practice? (05:15)
Disclosures: Mark Loeb discloses grant/research support from CIHR, WHO and Seqirus.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the American College of Cardiology Annual Meeting 2022
Share this Video
Related Videos In Heart Failure
Caroline Sindet-Pedersen, ESC 2022: SARS-CoV-2 mRNA vaccines in patients with heart failure
Studies investigating the safety and efficacy of the severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) mRNA vaccines lacked representation of patients with heart failure. In this touchCARDIO interview, we speak with Dr Caroline Sindet-Pedersen (Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark) to discuss the study presented at ESC 2022 that aimed to investigate […]
Mandeep Mehra, ESC 2022: HeartMate 3™ left ventricular assist device for heart failure, the MOMENTUM 3 study 2- and 5-year results
Following its positive 2-year results, the MOMENTUM 3 study in patients with heart failure was extended to assess 5-year outcomes of the HeartMate 3™ left ventricular assist device. In this touchCARDIO interview, we speak with Dr Mandeep Mehra (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) to discuss the MOMENTUM 3 study and […]
Mandeep Mehra, ESC 2022: Advances in left ventricular assist devices (LVADs) for heart failure and the advantages of the HeartMate 3™ LVAD
Left ventricular assist devices (LVADs) are utilised to treat patients with heart failure, the HeartMate 3™ being an example. In this touchCARDIO interview, we speak with Dr Mandeep Mehra (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA) to discuss the advances in LVADs and the advantages the HeartMate 3™ (HM3) LVAD holds over […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!